NMN (Nicotinamide Mononucleotide) vs NR (Nicotinamide Riboside)
Both raise NAD+ levels effectively. NR has more human clinical trials. NMN has better recent bioavailability data. For most users: choose based on price and availability—the difference is marginal.
Mechanism of Action
✓ TieBoth NMN and NR are NAD+ precursors. NR converts to NMN inside cells, then to NAD+. NMN is one step closer to NAD+ in the biosynthetic pathway. Until 2023, oral NMN absorption was debated—but isotope tracing studies now confirm direct uptake. Both pathways work. Winner: Tie.
Clinical Evidence
✓ NR (Nicotinamide Riboside)NR has 17 of 23 trials showing statistically significant NAD+ elevation (avg +40-60%). Best evidence for metabolic and liver health. NMN has 14 of 23 trials with significant elevation (avg +38-70%). Better evidence for muscle performance and insulin sensitivity. NR has a slight edge in total study count. Winner: NR (marginally).
Bioavailability
✓ NMN (Nicotinamide Mononucleotide)Recent 2024 studies using isotope-labeled NMN show direct absorption without breakdown to NR first. This was the main argument against NMN historically—now resolved. Sublingual NMN absorption is particularly effective. Winner: NMN (based on recent data).
Dosing & Cost
✓ NMN (Nicotinamide Mononucleotide)Effective NMN dose: 500mg/day. Effective NR dose: 1000mg/day. NMN is generally cheaper per effective dose. Winner: NMN.
Side Effects
✓ TieBoth are well-tolerated. Occasional flushing or GI discomfort reported for both at high doses. No significant safety differences. Winner: Tie.
Use NMN if: You want the most recent bioavailability data supporting direct absorption. You prefer sublingual administration. You want lower cost per effective dose. Use NR if: You prioritize the supplement with the longest clinical track record. You have specific interest in liver or metabolic health (where NR evidence is strongest). Honestly: For most longevity-focused users, the difference is marginal. Choose based on price and availability.